Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2019 2
2020 1347
2021 3600
2022 4378
2023 3531
2024 1224

Text availability

Article attribute

Article type

Publication date

Search Results

12,697 results

Results by year

Filters applied: . Clear all
Page 1
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Watanabe A, et al. Vaccine. 2023 Mar 10;41(11):1783-1790. doi: 10.1016/j.vaccine.2023.02.008. Epub 2023 Feb 8. Vaccine. 2023. PMID: 36774332 Free PMC article. Review.
We conducted a systematic review and meta-analysis to evaluate the association between COVID-19 vaccination and long COVID. METHODS: PubMed and EMBASE databases were searched on September 2022 without language restrictions (CRD42022360399) to identify prospective tr …
We conducted a systematic review and meta-analysis to evaluate the association between COVID-19 vaccination and long COVID. ME …
A systematic review of racial/ethnic and socioeconomic disparities in COVID-19.
Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. Khanijahani A, et al. Int J Equity Health. 2021 Nov 24;20(1):248. doi: 10.1186/s12939-021-01582-4. Int J Equity Health. 2021. PMID: 34819081 Free PMC article. Review.
The target population was the population of the countries during the COVID-19 pandemic. The exposures were defined as belonging to racial/ethnic minority groups and/or low SES. The primary outcomes of interest include (1) death from COVID …
The target population was the population of the countries during the COVID-19 pandemic. The exposures were defin …
How to interpret and use COVID-19 serology and immunology tests.
Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Ong DSY, et al. Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8. Clin Microbiol Infect. 2021. PMID: 33975005 Free PMC article. Review.
T-cell responses against SARS-CoV-2 have also been detected in recovered COVID-19 patients with no detectable antibodies. ...Combining molecular diagnostics with serological tests may optimize the detection of COVID-19. As not all …
T-cell responses against SARS-CoV-2 have also been detected in recovered COVID-19 patients with no detect …
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.
Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, Watkinson P, Khunti K, Harnden A, Coupland CAC, Channon KM, Mills NL, Sheikh A, Hippisley-Cox J. Patone M, et al. Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14. Nat Med. 2022. PMID: 34907393 Free PMC article.
We undertook a self-controlled case series study of people aged 16 or older vaccinated for COVID-19 in England between 1 December 2020 and 24 August 2021 to investigate hospital admission or death from myocarditis, pericarditis and cardiac arrhythmias in the 1-28 da …
We undertook a self-controlled case series study of people aged 16 or older vaccinated for COVID-19 in England between 1 Decem …
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. Luxi N, et al. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. Drug Saf. 2021. PMID: 34739716 Free PMC article. Review.
To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 Vaccine Janssen, Spikevax (previously COVID-19 Vaccine Moderna) and Vax …
To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent …
COVID-19 Vaccine Hesitancy in the United States: A Systematic Review.
Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, Yousaf Z, Seboka BT, Ullah I, Lin CY, Pakpour AH. Yasmin F, et al. Front Public Health. 2021 Nov 23;9:770985. doi: 10.3389/fpubh.2021.770985. eCollection 2021. Front Public Health. 2021. PMID: 34888288 Free PMC article.
Vaccine hesitancy in the US throughout the pandemic has revealed inconsistent results. This systematic review has compared COVID-19 vaccine uptake across US and investigated predictors of vaccine hesitancy and acceptance across different groups. ...Sex, race, …
Vaccine hesitancy in the US throughout the pandemic has revealed inconsistent results. This systematic review has compared COVID-1 …
Double standards redux.
Macklin R. Macklin R. Indian J Med Ethics. 2021 Apr-Jun;VI(2):1-7. doi: 10.20529/IJME.2021.021. Indian J Med Ethics. 2021. PMID: 33908355 Free article.
It is fair to say that nothing is more pressing in today's world than bringing an end to the Covid-19 pandemic. Or to be more precise, if not an end, then the quickest and most effective reduction of mortality and morbidity from the disease in every country where in …
It is fair to say that nothing is more pressing in today's world than bringing an end to the Covid-19 pandemic. Or to be more …
Age-specific mortality and immunity patterns of SARS-CoV-2.
O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H. O'Driscoll M, et al. Nature. 2021 Feb;590(7844):140-145. doi: 10.1038/s41586-020-2918-0. Epub 2020 Nov 2. Nature. 2021. PMID: 33137809 Free article.
Estimating the size of the coronavirus disease 2019 (COVID-19) pandemic and the infection severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is made challenging by inconsiste …
Estimating the size of the coronavirus disease 2019 (COVID-19) pandemic and the infection severity of severe …
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, Lyons RA, Kee F, Sheikh A, Rahman S, Valabhji J, Harrison EM, Sellen P, Haq N, Semple MG, Johnson PWM, Hayward A, Nguyen-Van-Tam JS. Hippisley-Cox J, et al. BMJ. 2021 Sep 17;374:n2244. doi: 10.1136/bmj.n2244. BMJ. 2021. PMID: 34535466 Free PMC article.
DESIGN: Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SARS-CoV-2 results, hospital admissions, systemic anticancer treatment, radiotherapy, and the national death and cance …
DESIGN: Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, …
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Agrawal U, Bedston S, McCowan C, Oke J, Patterson L, Robertson C, Akbari A, Azcoaga-Lorenzo A, Bradley DT, Fagbamigbe AF, Grange Z, Hall ECR, Joy M, Katikireddi SV, Kerr S, Ritchie L, Murphy S, Owen RK, Rudan I, Shah SA, Simpson CR, Torabi F, Tsang RSM, de Lusignan S, Lyons RA, O'Reilly D, Sheikh A. Agrawal U, et al. Lancet. 2022 Oct 15;400(10360):1305-1320. doi: 10.1016/S0140-6736(22)01656-7. Lancet. 2022. PMID: 36244382 Free PMC article.
BACKGROUND: Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. ...We fitted ti …
BACKGROUND: Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious ill …
12,697 results
You have reached the last available page of results. Please see the User Guide for more information.